Adaptive Biotechnologies Corp. (ADPT)
16.08
-0.04
(-0.25%)
USD |
NASDAQ |
Mar 03, 16:00
16.09
+0.01
(+0.06%)
After-Hours: 20:00
Adaptive Biotechnologies EPS Diluted (Quarterly) : -0.0887 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Gilead Sciences, Inc. | 1.742 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Arcellx, Inc. | -1.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.58M |
| Revenue (Quarterly) | 71.68M |
| Total Expenses (Quarterly) | 85.26M |
| Enterprise Value | 2.462B |
| Gross Profit Margin (Quarterly) | 71.37% |
| Profit Margin (Quarterly) | -18.94% |
| Earnings Yield | -2.48% |
| Normalized Earnings Yield | -2.480 |